​

Absci (ABSI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ABSI Stock Forecast

Absci (ABSI) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $12.40, with a high of $16.00 and a low of $9.00. This represents a 64.02% increase from the last price of $7.56.

- $4 $8 $12 $16 $20 High: $16 Avg: $12.4 Low: $9 Last Closed Price: $7.56

ABSI Stock Rating

Absci stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (76.92%), 1 Hold (7.69%), 2 Sell (15.38%), and 0 Strong Sell (0.00%).

Buy
Total 13 2 1 10 0 Strong Sell Sell Hold Buy Strong Buy

ABSI Price Target Upside V Benchmarks

TypeNameUpside
StockAbsci64.02%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-68
Avg Price Target-$11.02$9.80
Last Closing Price$7.56$7.56$7.56
Upside/Downside-45.77%29.63%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26281--11
Jun, 26271--10
May, 26261--9
Apr, 26261--9
Mar, 26261--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 25, 2026Morgan Stanley$10.00$10.08-0.79%32.28%
Jun 25, 2026H.C. Wainwright$16.00$10.0858.73%111.64%
Jun 15, 2026Guggenheim$15.00$6.80120.59%98.41%
Jun 04, 2026Leerink Partners$12.00$5.94102.02%58.73%
May 28, 2026BTIG$9.00$5.1674.42%19.05%
May 14, 2026Morgan Stanley$4.10$5.62-27.05%-45.77%
Jan 08, 2026Morgan Stanley$4.32$4.027.46%-42.86%
Dec 17, 2025H.C. Wainwright$8.00$3.44132.56%5.82%
Mar 21, 2024Daniel AriasStifel Nicolaus$6.00$5.2813.64%-20.63%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 25, 2026Morgan StanleyPositivePositivehold
Jun 25, 2026H.C. WainwrightBuyBuyhold
Jun 15, 2026GuggenheimBuyBuyhold
May 28, 2026BTIGBuyinitialise
Jan 08, 2026Morgan StanleyOverweightReducedowngrade
Dec 17, 2025H.C. WainwrightBuyBuyhold
Apr 16, 2025KeyBancOverweightOverweighthold
Oct 01, 2024GuggenheimBuyinitialise
Aug 15, 2024Cowen & Co.BuyBuyhold
Jul 03, 2024Morgan StanleyOverweightinitialise

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.11$-1.15$-1.20$-0.94$-0.84---
Avg Forecast$-1.90$-1.17$-1.08$-0.86$-0.76$-0.62$-0.58$-0.25
High Forecast$-0.69$-0.42$-1.06$-0.82$-0.68$-0.38$-0.25$-0.07
Low Forecast$-5.02$-3.57$-1.11$-0.90$-0.84$-0.85$-1.06$-0.84
Surprise %-41.58%-1.71%11.11%9.30%10.53%---

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.78M$5.75M$5.72M$4.53M$2.80M---
Avg Forecast$5.05M$9.31M$6.40M$6.05M$15.94M$33.96M$41.02M$57.30M
High Forecast$11.43M$24.09M$7.14M$7.49M$37.66M$94.60M$114.27M$159.64M
Low Forecast$2.59M$4.70M$5.29M$5.05M$8.39M$15.55M$18.78M$26.24M
Surprise %-5.38%-38.25%-10.66%-25.11%-82.43%---

Net Income Forecast

$-500M $-400M $-300M $-200M $-100M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-100.96M$-104.90M$-110.57M$-103.11M$-115.18M---
Avg Forecast$-174.88M$-107.32M$-100.12M$-79.48M$-70.13M$-56.63M$-88.50M$-23.38M
High Forecast$-63.92M$-38.33M$-98.01M$-75.91M$-63.01M$-34.67M$-23.01M$-6.90M
Low Forecast$-461.69M$-328.84M$-102.23M$-83.06M$-77.24M$-78.59M$-97.55M$-77.64M
Surprise %-42.27%-2.25%10.43%29.72%64.25%---

ABSI Forecast FAQ

Is Absci stock a buy?

Absci stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 1 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Absci is a favorable investment for most analysts.

What is Absci's price target?

Absci's price target, set by 13 Wall Street analysts, averages $12.4 over the next 12 months. The price target range spans from $9 at the low end to $16 at the high end, suggesting a potential 64.02% change from the previous closing price of $7.56.

How does Absci stock forecast compare to its benchmarks?

Absci's stock forecast shows a 64.02% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Absci over the past three months?

  • July 2026: 18.18% Strong Buy, 72.73% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 20.00% Strong Buy, 70.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.

What is Absci’s EPS forecast?

Absci's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.62, marking a -26.19% decrease from the reported $-0.84 in 2025. Estimates for the following years are $-0.58 in 2027, and $-0.25 in 2028.

What is Absci’s revenue forecast?

Absci's average annual revenue forecast for its fiscal year ending in December 2026 is $33.96M, reflecting a 1112.72% increase from the reported $2.8M in 2025. The forecast for 2027 is $41.02M, and $57.3M for 2028.

What is Absci’s net income forecast?

Absci's net income forecast for the fiscal year ending in December 2026 stands at $-56.629M, representing a -50.84% decrease from the reported $-115M in 2025. Projections indicate $-88.498M in 2027, and $-23.375M in 2028.